Pages that link to "Q38033522"

The following pages link to Methotrexate: mechanism of action in rheumatoid arthritis (Q38033522):

Displaying 39 items.

• Subcutaneous or intramuscular methotrexate for rheumatoid arthritis (Q24187565) (← links)
• Successful methotrexate therapy for adult Still's disease with Marked thrombocytopenia (Q33503236) (← links)
• Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in culture (Q33565841) (← links)
• Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? (Q33869850) (← links)
• Mechanisms of action of methotrexate. (Q33957205) (← links)
• Methotrexate: a detailed review on drug delivery and clinical aspects (Q34247680) (← links)
• Methotrexate in rheumatoid arthritis. An update (Q34291348) (← links)
• Combination therapy in autoimmune disease: vasculitis (Q34309769) (← links)
• A systematic review of oral methotrexate for multiple sclerosis (Q34556023) (← links)
• Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. (Q34758283) (← links)
• FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells (Q35042532) (← links)
• Fibrogenesis in cirrhosis. Potential for therapeutic intervention (Q36368951) (← links)
• Does methotrexate increase the risk of infection or malignancy? (Q38555334) (← links)
• Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver (Q38828358) (← links)
• The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease (Q39297229) (← links)
• Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease (Q40388190) (← links)
• Infections during low-dose methotrexate treatment in rheumatoid arthritis. (Q40478116) (← links)
• A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis (Q40626172) (← links)
• Low-dose methotrexate treatment in elderly patients with bullous pemphigoid (Q40705517) (← links)
• Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis (Q40714819) (← links)
• Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks? (Q40800506) (← links)
• Effects of antirheumatic agents on cytokines (Q41133430) (← links)
• Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity (Q41757845) (← links)
• Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis (Q42284908) (← links)
• Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis (Q43947279) (← links)
• Effects of methotrexate exposure on medaka (Oryzias latipes) testes (Q47159709) (← links)
• Low-dose methotrexate in the treatment of widespread morphea (Q47685036) (← links)
• Long Non-Coding RNAs in Vascular Inflammation. (Q52584216) (← links)
• An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis (Q64100779) (← links)
• Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis (Q67476173) (← links)
• Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs (Q70958845) (← links)
• Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation (Q71917533) (← links)
• One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors (Q72650153) (← links)
• Better effect of methotrexate on C-reactive protein during daily compared to weekly treatment in rheumatoid arthritis (Q72897258) (← links)
• Localized and systemic scleroderma show different histological responses to methotrexate therapy (Q73687981) (← links)
• Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy (Q77965259) (← links)
• Durability of treatment with methotrexate in Venezuelan patients with rheumatoid arthritis (Q79356042) (← links)
• Intra-articular methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis: a clinical and sonographic study (Q81834001) (← links)
• Cervus and cucumis peptides ameliorates bone erosion in experimental arthritis by inhibiting osteoclastogenesis (Q92550919) (← links)